MAGE-A1 promotes melanoma proliferation and migration through C-JUN activation

Copyright © 2016. Published by Elsevier Inc..

MAGE-A1 belongs to the chromosome X-clustered genes of cancer-testis antigen family and is normally expressed in the human germ line but is also overexpressed in various tumors. Previous studies of MAGE-A1 in melanoma mainly focused on methylation changes or its role in immunotherapy, however, its biological functions in melanoma have remained unknown. In order to determine the role of MAGE-A1 in melanoma growth and metastasis, we manipulated melanoma cell lines with overexpression and knockdown of MAGE-A1. Integration of cell proliferation assays, transwell migration and invasion assays, and RNA-Seq analysis revealed that up-regulation of MAGE-A1 dramatically promoted proliferation, migration, and invasion of human melanoma cell lines in vitro, while down-regulation of MAGE-A1 inhibited those characteristics associated with tumor cells. Furthermore, transcriptome sequencing revealed that MAGE-A1 exerts its tumor promoting activity by activating p-C-JUN directly or through ERK-MAPK signaling pathways. Based on our findings, we propose that MAGE-A1 may be a potential therapeutic target for melanoma patients.

Medienart:

E-Artikel

Erscheinungsjahr:

2016

Erschienen:

2016

Enthalten in:

Zur Gesamtaufnahme - volume:473

Enthalten in:

Biochemical and biophysical research communications - 473(2016), 4 vom: 13. Mai, Seite 959-965

Sprache:

Englisch

Beteiligte Personen:

Wang, Dong [VerfasserIn]
Wang, Junyun [VerfasserIn]
Ding, Nan [VerfasserIn]
Li, Yongjun [VerfasserIn]
Yang, Yaran [VerfasserIn]
Fang, Xiangdong [VerfasserIn]
Zhao, Hua [VerfasserIn]

Links:

Volltext

Themen:

C-JUN
EC 2.7.11.24
ERK-MAPK
Extracellular Signal-Regulated MAP Kinases
Journal Article
MAGE-A1
MAGEA1 protein, human
Melanoma-Specific Antigens
Proto-Oncogene Proteins c-jun
RNA-seq
Research Support, Non-U.S. Gov't
Tumor metastasis

Anmerkungen:

Date Completed 13.06.2017

Date Revised 09.04.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.bbrc.2016.03.161

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM259080241